baber/WOPTO huggingface dataset:
Patent NZ-593014-A (NZ)
Title: Cartridge, pharmaceutical dispenser for solid medicament portions and applications of said cartridge and said pharmaceutical dispenser
Inventor: LEIFELD SABINE
IPC: A61J1/03
Filed: 2009-11-14
Abstract: 593014 The disclosure relates to the safe storage and simple and safe taking of tablets (T) by a user by means of a cartridge (900) that can be used in a pharmaceutical dispenser (1) for solid pharmaceutical portions and that is designed having a storage space for accommodating the pharmaceutical portions, and by means of a pharmaceutical dispenser for this cartridge. The cartridge comprises a separation device (910) that is adapted to dispense defined pharmaceutical portions and that comprises a movable device for separating a defined pharmaceutical portion from the storage space and for releasing out of the pharmaceutical dispenser. The separation device is designed for creating an operative connection to an activation device in the pharmaceutical dispenser.
Patent NZ-594762-A (NZ)
Title: Roaming services network and overlay networks
Inventor: RALEIGH GREGORY G
IPC: H04L12/14
Filed: 2010-01-18
Abstract: An end-user device, comprises one or more modems for enabling the end-user device to connect wirelessly to at least a home access network and a roaming access network; a user interface; memory configured to store a first control policy, the first control policy configured to allow the end-user device to send a first data communication over the roaming access network and to block the end-user device from sending a second data communication over the roaming access network; and one or more processors configured to determine that the end-user device is connected to or attempting to connect to the roaming access network, and when the end-user device is connected to or attempting to connect to the roaming access network, apply the first control policy to the first data communication and to the second data communication.
Patent NZ-595486-A (NZ)
Title: Locking threaded fastener with a spring and locking ring to prevent removal of fastener with a standard tool
Inventor: CAMPAU DANIEL N
IPC: F16B39/20
Filed: 2010-03-04
Abstract: The specification discloses a locking threaded fastener (10) including a body (12), a coil spring (14), and a compression ring (16). The body is hex-shaped (18) and defines a partially threaded bore (24), an external circumferential groove (32), and a passage (34) extending radially between the bore and the groove. The coil spring is located within the bore and includes a first end (38) angularly fixed with respect to the body and a second end (40) extending through the passage and into the groove. The compression ring is located within the groove and defines an opening (44) receiving the second end of the coil spring. The compression ring is free to move within the groove and includes portions that extending radially outwardly beyond the flats (22) of the hex shape. When a conventional wrench is engaged with the hex shape, the wrench compresses the compression ring to prevent relative angular movement between the ring and the body.
Patent NZ-595599-A (NZ)
Title: Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
Inventor: PFEIFER JOSEPH W III
IPC: A23D9/007
Filed: 2009-03-19
Abstract: 595599 Discloses a microbial oil comprising a triglyceride fraction of 70% by weight, wherein the docosahexaenoic acid (DHA) content of the fraction is 50% by weight and the docosapenaenoic acid n-6 of the triglyceride fraction is 0.5% - 6% by weight Or a microbial oil comprising a triglyceride fraction of 70% by weight, wherein the docosahexaenoic acid (DHA) content of the fraction is 40% by weight and the docosapenaenoic acid n-6 of the triglyceride fraction is 0.5% - 6% by weight or a microbial oil comprising a triglyceride fraction of 70% by weight, wherein the docosahexaenoic acid (DHA) content of the fraction is 60% by weight.
Patent NZ-601022-A (NZ)
Title: Diagnosis and treatment of cancer using anti-ereg antibody
Inventor: ABURATANI HIROYUKI
IPC: A61K39/395
Filed: 2007-10-12
Abstract: Disclosed is the use of an EREG protein in an isolated sample as a cancer diagnostic marker, wherein the sample used for the diagnosis is an immobilized specimen of a tissue or cell collected from the body of an organism, wherein the EREG protein expressed on a cell membrane is detected. Further disclosed are diagnostic methods using the anti-EREG antibody which specifically binds a cell surface antigen of for detecting cancer.
Patent NZ-601567-A (NZ)
Title: Process for production of delta-9-tetrahydrocannabinol
Inventor: BURDICK DAVID C
IPC: C07D311/78
Filed: 2006-09-28
Abstract: 601567 Disclosed are intermediates which are useful in the synthesis of (-)-trans-delta-9-tetrahydrocannabinol, and derivative compounds thereof as represented by the general formula (I), wherein: R1 is H, substituted or unsubstituted alkyl, carboxylic ester, or acyl; R2 is H, OH, protected hydroxyl, substituted or unsubstituted. alkyl, alkenyl, alkynyl, acyl, aryl or heteroaryl; R3 is H, substituted or unsubstituted alkyl, carboxylic ester, or acyl; R8, R9, and R10 are the same or different and independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or halo; and R8 and R9; R8 and R10; or R9 and R10; or R8, R9, and R10 can together result in the formation of a cyclic moiety. Representative compounds include delta-9-tetrahydrocannabinol (1S)-10-camphorsulfonate.
Patent NZ-602265-A (NZ)
Title: Temporary roof anchor having shock absorbing means
Inventor: POLDMAA ARVO
IPC: A62B35/00
Filed: 2012-09-05
Abstract: 602265 Disclosed is a temporary roof safety anchor for preventing injuries from falls that has a serpentine plastic deforming shock absorbing anchor secured by flexible webbing straps fixed to the roof. The temporary roof anchor 11 for fitment to a roof support structure 23b comprises a first flexible attachment means 15 for temporary fitment to the roof support structure; second flexible attachment means 16 remote from the first attachment means for attaching safety equipment; and shock absorbing means 13 having a plastically deformable region extending between the first and second attachment means in a first length when not subject to a deformation force corresponding to a critical sudden load, the shock absorbing means lying substantially in a single plane and comprising a substantially rigid structure that, when subject to the critical sudden load, deforms, elongating to a greater length than the first length.
Patent NZ-607324-A (NZ)
Title: Recombinant neisseria meningitidis por a porin proteins.
Inventor: JENNINGS MICHAEL PAUL
IPC: G01N33/68
Filed: 2011-08-01
Abstract: Disclosed is an isolated protein comprising an amino acid sequence of a PorA protein of Neisseria meningitides, wherein one or more variable regions of the PorA protein are disrupted by comprising one or more PorA conserved regions, or at least six (6) contiguous conserved region amino acids.
Patent NZ-609914-A (NZ)
Title: Securing device
Inventor: MCKINLEY MATTHEW HENRY
IPC: E04H17/26
Filed: 2012-10-11
Abstract: 609914 A reel holder 1 including at least one hook 5 configured to attach the reel holder 1 to an elongated member 7 and a securing mechanism 6 moveable into different positions by an actuating mechanism 2. In one of the positions, the securing mechanism 6 forms a barrier over at least a portion of an open end of the hook 5 to retain a portion of the elongated member 7 within the hook 5.
Patent NZ-611044-A (NZ)
Title: A hydraulic hitch assembly
Inventor: ESSEX STUART ALEXANDER
IPC: E02F3/26
Filed: 2011-11-11
Abstract: 611044 A hydraulic hitch assembly including oppositely directed jaws operable to releasably grip an attachment including two transverse hinge pins, wherein one of the oppositely directed jaws is fixed relative to the hitch assembly, and the other jaw is moveable between a withdrawn position, in which the oppositely directed jaws can be fitted between the two transverse hinge pins of the attachment, and an extended position, in which the two transverse hinge pins are gripped by the oppositely directed jaws, the hydraulic hitch assembly further including a safety mechanism including an arm moveable between an engaged position and a disengaged position, wherein when the arm is in the engaged position, the arm prevents the transverse hinge pin from being released from the fixed jaw.
Patent NZ-615726-A (NZ)
Title: Dosing regimens for the treatment of fabry disease
Inventor: GREENE DOUGLAS STUART
IPC: A61K31/445
Filed: 2012-03-08
Abstract: The disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin ((2R,3S,4R,5S)-2-(hydroxymethyl) piperdine-3,4,5-triol) or its salt migalastat hydrochloride and agalactosidase A (a-Gal A) enzyme replacement therapy for the treatment of Fabry disease. The a-Gal A enzyme replacement therapy includes replacement enzymes agalsidase alpha (Replagal) and agalsidase beta (Fabrazyme). Disclosed is a dose of 50-600 mg of 1-deoxygalactonojirimycin or migalastat hydrochloride, administered to patients fasted for up to four hours before enzyme replacement therapy and/or administered up to four hours prior to enzyme replacement therapy where subsequent therapy is administered every two to four weeks.
Patent NZ-624222-A (NZ)
Title: Paste comprising non-steroidal anti-inflammatory drug
Inventor: REYNOLDS LOUISE
IPC: A61P29/00
Filed: 2012-10-16
Abstract: Provided is an oral paste comprising: (i) at least one non-steroidal anti-inflammatory drug (NSAID); (ii) at least one viscosity modifying agent; and (iii) a liquid vehicle. Preferred NSAIDs include meloxicam and piroxicam. Preferred viscosity modifying agents include hydroxypropyl cellulose and xanthan gum or mixtures thereof.
Patent NZ-628382-A (NZ)
Title: Human binding molecules capable of binding to and neutralizing influenza b viruses and uses thereof
Inventor: KWAKS THEODORUS HENDRIKUS JACOBUS
IPC: C07K16/10
Filed: 2013-03-07
Abstract: Disclosed is a binding molecule capable of specifically binding to hemagglutinin (HA) of influenza B virus strains of the B/Yamagata and B/Victoria lineage, and capable of neutralising said influenza B virus strains of the B/Yamagata and/or B/Victoria lineage, wherein the binding molecule does not bind to HA of influenza A viruses, and wherein the binding molecule comprises a heavy chain CDR1 comprising the amino acid sequence of SEQ ID NO: 7, a heavy chain CDR2 comprising the amino acid sequence of SEQ ID NO: 8, and a heavy chain CDR3 comprising the amino acid sequence of SEQ ID NO: 9, and a light chain CDR1 comprising the amino acid sequence of SEQ ID NO: 10, a light chain CDR2 comprising the amino acid sequence of SEQ ID NO: 11, and a light chain CDR3 comprising the amino acid sequence of SEQ ID NO:12 or SEQ ID NO: 13, wherein the sequences are as disclosed in the complete specification.
Patent NZ-629077-A (NZ)
Title: Non-human animals expressing ph-sensitive immunoglobulin sequences
Inventor: MACDONALD LYNN
IPC: C12N15/85
Filed: 2013-03-15
Abstract: Disclosed is a genetically modified non-human animal comprising in its germline an immunoglobulin locus that comprises an unrearranged immunoglobulin variable gene sequence comprising a substitution of at least one non-histidine codon with a histidine codon or an insertion of at least one histidine codon, wherein the substituted or inserted histidine codon is not encoded by a corresponding wild-type gene segment, and wherein the nonhuman animal expresses a nucleotide sequence encoding an immunoglobulin variable domain that comprises a histidine amino acid derived from the substitution of the at least one non-histidine codon or insertion of the at least one histidine codon in the unrearranged immunoglobulin variable gene sequence. Also disclosed are methods for making such a non-human animal.
Patent NZ-700477-A (NZ)
Title: Inactivated dengue virus vaccine with aluminium-free adjuvant
Inventor: TOUSSAINT JEAN-FRANCOIS
IPC: C07K14/18
Filed: 2010-02-16
Abstract: Disclosed is an immunogenic composition comprising at least one inactivated dengue virus antigen and an aluminium-free adjuvant, wherein the adjuvant comprises an oil-in-water emulsion carrier comprising a metabolisable oil, a tocol and an emulsifier.
Patent NZ-708205-A (NZ)
Title: Immunotherapy against several tumors including gastrointestinal and gastric cancer
Inventor: LEWANDROWSKI PETER
IPC: G01N33/50
Filed: 2011-03-15
Abstract: Disclosed is a peptide consisting of the sequence according to SEQ ID No. 3 (NYLPFIMEL) that induces T cells crossreacting with said peptide.
Patent NZ-714966-A (NZ)
Title: Male and female parts for a wear assembly of an earth-moving machine’s bucket
Inventor: TRIGINER BOIXEDA JORGE
IPC: E02F9/28
Filed: 2014-07-17
Abstract: A wear assembly of an earth-moving machine’s bucket comprises a male part (1) and a female part (2), both of which in turn comprises a nose (10) (male part) or cavity (20) (female part) provided with an upper contact surface and a lower contact surface. The upper contact surface comprises an upper front contact portion (14) that extends backward from the tip of the nose or the bottom of the cavity and the lower contact surface comprises a lower front contact portion (13) that extends likewise, one of said upper and lower front contact portions being concave and the other being convex. Analogously, the upper contact surface comprises an upper back contact portion (16) that extends forward from the base of the nose or the mouth of the cavity, and the lower contact surface comprises a lower back contact portion (15) that extends likewise, one of said upper and lower back contact portions being concave and the other being convex. The effect of the assembly is to alleviate the effect of the stresses on the wear assembly by redirecting or reducing them.
Patent NZ-721206-A (NZ)
Title: Protective cap for a dispenser, and discharge device for discharging pharmaceutical and/or cosmetical liquids
Inventor: SHANKAR SAI
IPC: B65D83/00
Filed: 2014-12-16
Abstract: The invention relates to a protective cap for a dispenser, and to a dispenser for discharging pharmaceutical and/or cosmetical liquids, wherein the dispenser (2) has a liquid reservoir (21) and an outlet opening (24) through which the liquid (4) can be discharged into a surrounding atmosphere. The protective cap (3) comprises an outer cap (31) and an inner element (32) inserted therein, wherein either at least one ventilation channel (33), which can be closed by means of a shut-off element and provides communication between an interior of the protective cap (3) and an external environment, is formed between the outer cap (31) and the inner element (32), or the inner element closes a ventilation opening of the outer cap (31). The invention aims to provide a functional dispenser cap while preventing contamination before a first use.
Patent NZ-728217-A (NZ)
Title: Container having primary and secondary support surfaces
Inventor: PAREDES RAUL
IPC: B65D21/02
Filed: 2013-08-02
Abstract: A container (22, 122, 222, 322, 422, 522, 622) having a longitudinal axis A and including a body (26, 126, 226, 326, 426, 526, 626) and a neck finish (34, 134, 234, 334, 434, 534) extending from the body along and coaxial with the longitudinal axis. The body includes a base (28, 128, 228, 328, 428, 528, 628) having a primary support surface (48, 148, 648), and a sidewall (30, 130, 230, 330, 430, 530, 630) extending from the base and including a facet having a secondary support surface (58, 158, 258, 358, 458, 558, 658) oriented at a tilt angle that is acute with respect to the axis and obtuse with respect to the primary support surface, the facet also having a recessed portion (60) within the secondary support surface. The neck finish includes a cylindrical outer surface (36) and one or more closure engagement features (38) on the cylindrical outer surface. The container has improved gripping characteristics, and can be tilted to facilitate access to partially consumed and diminishing product in the container.
Patent NZ-730195-A (NZ)
Title: Heterocyclic compounds and use thereof
Inventor: SHIA KAK-SHAN
IPC: C07D403/14
Filed: 2015-09-21
Abstract: Heterocyclic compounds of Formula (I) shown herein. Also disclosed are pharmaceutical compositions containing the heterocyclic compounds and methods of using the heterocyclic compounds to mobilize hematopoietic stem cells and endothelial progenitor cells into the peripheral circulation. Further provided are methods for treating tissue injury, cancer, inflammatory disease, and autoimmune disease with the heterocyclic compounds.
Patent NZ-730526-A (NZ)
Title: Modular waste transfer station (mwts)
Inventor: LACEY GRANT
IPC: B65F9/00
Filed: 2015-11-02
Abstract: The invention is to improve current compliance, safety and diversion requirements for existing methods, bins and systems of modular waste transfer stations. Open faced bins allow human entry for sorting, segregation or quarantining waste before it is moved to or mixed with bulk waste stations. Bins are located in covered or uncovered bays located away from waste stations. Stops and guides for precise and safe placement of bins in bays are provided. Bins have quick hitch connection points. To collect, store and redirect leachates in bins, a liquid capture zone and drain hole is provided. Bay design prevents public access to machine areas and adjacent bays. These features of the bin and waste station system allow the end user to sort through the different types of waste safely and without contact with heavy lifting and large machinery. The bins, as mentioned above, have a compartment for storing leachate this prevents the leachate from entering the local environment.
Patent NZ-732925-A (NZ)
Title: Compact oronasal patient interface
Inventor: RAJE MILIND CHANDRAKANT
IPC: A62B18/08
Filed: 2004-12-24
Abstract: Disclosed is an oronasal patient interface with nozzle assembly and mouth mask sealing around exterior of mouth via gusset in cushion.
Patent NZ-739450-A (NZ)
Title: Defined composition gene modified t-cell products
Inventor: JENSEN MICHAEL
IPC: C12N5/10
Filed: 2015-04-08
Abstract: Aspects of the invention described herein, concern approaches to make genetically modified T-cells comprising a chimeric antigen receptor for human therapy. In some alternatives, the methods utilize CD4+ and/or CD8+ T-cells from a mixed T-cell population, such as peripheral blood or apheresis derived mononuclear cells. The CD4+ and/or CD8+ T-cells are activated, genetically modified, and propagated in separate or isolated cultures with one or more cytokines, which support survival, engraftment and/or proliferation as well as promoting or inducing the retention of cell surface receptors such as CD62L, CD28, and/or CD27. Preferably, such cytokines may be IL2, IL7, IL21, or IL15. The CAR may be specific for CD19. Included herein are also methods of treatment, inhibition, amelioration or elimination of a cancer, particularly leukaemia, by administering one or more types of the genetically engineered T-cells to a subject.
Patent NZ-747017-A (NZ)
Title: Debranching enzyme modified starch, the preparing method and use thereof in hard capsule production
Inventor: PEI-HSUAN LEE
IPC: C12P19/16
Filed: 2018-10-05
Abstract: The present invention relates to a modified starch and a method for obtaining the modified starch by using a debranching enzyme, such as isoamylase, pullulanase, limit dextrinase and the like. The debranching enzyme modified starch of present invention exhibits excellent film-forming capacity, film strength, and gelation ability, so as to be used as a material for making hard capsules without the use of coagulants and plasticizers.
Patent NZ-751777-A (NZ)
Title: Pharmaceutical composition and methods of uses
Inventor: LI YUHUA
IPC: A61K47/61
Filed: 2017-08-18
Abstract: The present invention provides compositions or formulations comprising the combination of a 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione derivative of Formula (I), or a salt thereof or hydrate of the foregoing, and a beta-cyclodextrin; or in further combination with an excipient comprising L-Arginine or other additives, wherein the compositions or formulations increases water solubility and oral bioavailability of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and its related compounds. The method of making or using the compositions or formulations is also disclosed. Such compositions or formulations may be used in treatment of certain diseases including asthma through inhibition of matrix metalloproteinase -12.
Patent NZ-759917-A (NZ)
Title: Apparatus for weed control
Inventor: OUTRAM JERRY
IPC: A01M7/00
Filed: 2018-07-02
Abstract: The present invention relates to an apparatus for weed control. It is described to provide (210) a processing unit with at least one image of an environment. The processing unit analyses (220) the at least one image to determine at least one location within the environment for activation of at least one mulch application unit. The at least one mulch application unit is configured to apply at least one mulch to the at least one location for weed control. An output unit outputs (230) information that is useable to activate the at least one mulch application unit.
Patent NZ-759940-A (NZ)
Title: A universal vaccine based on shared tumor neoantigens for prevention and treatment of micro satellite instable (msi) cancers
Inventor: NICOSIA ALFREDO
IPC: C07K14/47
Filed: 2018-07-12
Abstract: This invention relates to a method of selecting a collection of frame- shift peptides (CFSPs) to produce a universal cancer vaccine peptide collection (CVP) for prophylaxis and treatment of patients with hereditary and sporadic micro- satellite instability (MSI) tumors. This invention relates as well to a method of producing a CVP by selecting a subset of frame-shift peptides (FSPs) from the CFSP and optionally modifying the FSP’s amino acid (aa) sequence to generate modified FSPs (mFSPs). The invention further relates to nucleic acid collections encoding a CVP of FSPs and/or mFSPs in one or more vaccine vectors that can be used also simultaneously. These CVPs, nucleic acids and vectors are used for the prophylaxis or treatment of MSI cancers.
Patent NZ-767643-A (NZ)
Title: Mask vent
Inventor: JUDSON DANIEL ROBERT
IPC: A61M16/20
Filed: 2008-08-25
Abstract: A mask system (220) configured to deliver air pressurized by a flow generator system above atmospheric pressure to an airway of a patient to treat sleep disordered breathing (SDB) by continuous positive airway pressure (CPAP). The mask system includes a mask (230) to deliver a flow of pressurized air to an airway of a patient and two inlet conduits (232) configured to deliver the flow of pressurized air to the mask. Each of the two inlet conduits includes a first end, a second end, and a tube wall forming a path for the flow of pressurized air between the first end and the second end. The first end of each of the two inlet conduits is configured to fluidly communicate with the flow generator system to receive the flow of pressurized air. The second end of each of the two inlet conduits is configured to fluidly communicate with a corresponding side of the mask to deliver the flow of pressurized air from the first end to the mask. The tube wall of each of the two inlet conduits is configured to extend from the first end at a position superior to the patient’s head, along a corresponding side of the patient’s head, and to the second end at the corresponding side of the mask. Each of the two inlet conduits includes a vent arrangement configured to discharge gas to atmosphere during therapy. The vent arrangement comprises a plurality of vent orifices (228) for gas washout, the plurality of vent orifices extending through the tube wall of each of the two inlet conduits. The vent arrangement comprises a diffuser media to diffuse vent flow.